China's Akeso Bets On IO Antibody Combo With First US IND

May 03 2019

• By Brian Yang

Chinese Bioventure Akeso Has Obtained An IND For Its Lead Asset • Source: Shutterstock

More from Immuno-oncology

More from Anticancer